Cargando…

Guillain‐Barré syndrome in a patient with antibodies against SARS‐COV‐2

Detalles Bibliográficos
Autores principales:	Helbok, R., Beer, R., Löscher, W., Boesch, S., Reindl, M., Hornung, R., Schiefecker, A.J., Deisenhammer, F., Pfausler, B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Neuropathies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323168/ https://www.ncbi.nlm.nih.gov/pubmed/32531083 http://dx.doi.org/10.1111/ene.14388

Ejemplares similares

Cerebrospinal fluid protein in Guillain–Barré syndrome: Need for age‐dependent interpretation
por: Hegen, Harald, et al.
Publicado: (2020)

Very early and early neurophysiological abnormalities in Guillain–Barré syndrome: A 4‐year retrospective study
por: Rasera, Andrea, et al.
Publicado: (2021)

Acute flaccid myelitis and Guillain–Barré syndrome in children: A comparative study with evaluation of diagnostic criteria
por: Helfferich, Jelte, et al.
Publicado: (2021)

Guillain–Barré syndrome following influenza vaccination: A 15‐year nationwide population‐based case–control study
por: Levison, Lotte Sahin, et al.
Publicado: (2022)

A diagnostic score for anti‐myelin‐associated‐glycoprotein neuropathy or chronic inflammatory demyelinating polyradiculoneuropathy in patients with anti‐myelin‐associated‐glycoprotein antibody
por: Doneddu, Pietro E., et al.
Publicado: (2022)

Pregnancy outcome in Charcot–Marie–Tooth disease: results of the CMT‐NET cohort study in Germany
por: Rudnik‐Schöneborn, S., et al.
Publicado: (2020)

Primary Sjögren syndrome‐related peripheral neuropathy: A systematic review and meta‐analysis
por: Liampas, Andreas, et al.
Publicado: (2022)

Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy
por: Kuitwaard, Krista, et al.
Publicado: (2021)

Randomized trial of intravenous immunoglobulin maintenance treatment regimens in chronic inflammatory demyelinating polyradiculoneuropathy
por: Kuitwaard, K., et al.
Publicado: (2020)

Early data on long‐term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2‐year update from the open‐label extension of the NEURO‐TTR trial
por: Brannagan, T. H., et al.
Publicado: (2020)

Contribution of sleep disturbances to fatigue in multiple sclerosis: a prospective study using clinical and polysomnographic parameters
por: Riccitelli, Gianna C., et al.
Publicado: (2021)

Dolichoarteriopathies of the extracranial internal carotid artery: The Plaque At RISK study
por: Dilba, Kristine, et al.
Publicado: (2021)

Quantitative magnetic resonance imaging of the brachial plexus shows specific changes in nerve architecture in chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy and motor neuron disease
por: van Rosmalen, Marieke H. J., et al.
Publicado: (2021)

Misdiagnosis and diagnostic pitfalls of chronic inflammatory demyelinating polyradiculoneuropathy
por: Broers, Merel C., et al.
Publicado: (2021)

Cardiovascular health and chronic axonal polyneuropathy: A population‐based study
por: Taams, Noor E., et al.
Publicado: (2021)

Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies
por: Kmezic, Ivan, et al.
Publicado: (2022)

Corneal nerve loss is related to the severity of painful diabetic neuropathy
por: Kalteniece, Alise, et al.
Publicado: (2021)

Real‐life experience with inotersen in hereditary transthyretin amyloidosis with late‐onset phenotype: Data from an early‐access program in Italy
por: Luigetti, Marco, et al.
Publicado: (2022)

Genetic evidence for the most common risk factors for chronic axonal polyneuropathy in the general population
por: Taams, Noor E., et al.
Publicado: (2022)

Association of plasma neurofilament light chain with disease activity in chronic inflammatory demyelinating polyradiculoneuropathy
por: Kapoor, Mahima, et al.
Publicado: (2022)

Validation of motor and functional scales for the evaluation of adult patients with 5q spinal muscular atrophy
por: Vázquez‐Costa, Juan F., et al.
Publicado: (2022)

Ictal apnea: A prospective monocentric study in patients with epilepsy
por: Micalizzi, Elisa, et al.
Publicado: (2022)

Frequency, entity and determinants of fatigue in Charcot–Marie–Tooth disease
por: Bellofatto, Marta, et al.
Publicado: (2022)

Electroencephalography functional connectivity—A biomarker for painful polyneuropathy
por: Topaz, Leah Shafran, et al.
Publicado: (2022)

Mutations in MYO9B are associated with Charcot–Marie–Tooth disease type 2 neuropathies and isolated optic atrophy
por: Cipriani, Silvia, et al.
Publicado: (2022)

Hindsight for ultrasound imaging/measurement of the tibial nerve (answer)
por: Dhanapalaratnam, Roshan, et al.
Publicado: (2022)

Caspr2 antibodies in herpes simplex encephalitis: an extension of the spectrum of virus induced autoimmunity? – A case report
por: Berek, Klaus, et al.
Publicado: (2022)

Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up
por: Wanschitz, Julia V., et al.
Publicado: (2020)

Risk of Neuropathy with Celiac Disease
por: Millichap, J. Gordon
Publicado: (2015)

Medical treatment of SUNCT and SUNA: a prospective open-label study including single-arm meta-analysis
por: Lambru, Giorgio, et al.
Publicado: (2021)

Autoantibodies against neuronal surface proteins in spontaneous subarachnoid and intracerebral haemorrhage
por: Hegen, Harald, et al.
Publicado: (2018)

Guillain-Barré syndrome and SARS-CoV-2
por: Lampe, Anne, et al.
Publicado: (2020)

Dimensions of SARS-CoV-2 associated Guillain-Barré syndrome
por: Finsterer, J., et al.
Publicado: (2021)

SARS-CoV-2 associated Guillain–Barré syndrome
por: Pelea, Teodor, et al.
Publicado: (2020)

Post SARS-CoV-2 Guillain-Barré syndrome
por: Arnaud, Souraya, et al.
Publicado: (2020)

Guillain–Barré Syndrome Associated with SARS-CoV-2
por: Toscano, Gianpaolo, et al.
Publicado: (2020)

SARS-CoV-2 Infection and Guillain-Barré Syndrome
por: Makhluf, Huda, et al.
Publicado: (2021)

Guillain–Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain–Barré syndrome
por: Ling, Ling, et al.
Publicado: (2021)

Is Guillain Barre syndrome truly caused by SARS-CoV-2?
por: Finsterer, Josef, et al.
Publicado: (2021)

Guillain-Barré syndrome related to SARS-CoV-2 infection
por: Bigaut, Kévin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sh0894msaumj4edmv9hv5a523o